LGND vs BIIB: Which Stock is Better?
Side-by-side comparison of Ligand Pharmaceuticals Inc and Biogen Inc in 2026
LGND
Ligand Pharmaceuticals Inc
$231.82
BIIB
Biogen Inc
$177.35
Key Metrics Comparison
| Metric | LGND | BIIB | Winner |
|---|---|---|---|
| Market Cap | $4.62B | $26.03B | BIIB |
| P/E Ratio | 37.82 | 20.04 | BIIB |
| EPS (TTM) | $6.13 | $8.85 | BIIB |
| Revenue Growth | 0.4% | -0.1% | LGND |
| Gross Margin | 64.3% | 78.9% | BIIB |
Analyze LGND
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LGND or BIIB a better investment?
Comparing LGND and BIIB: Ligand Pharmaceuticals Inc has a market cap of $4.62B while Biogen Inc has $26.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LGND and BIIB?
LGND (Ligand Pharmaceuticals Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LGND or BIIB?
Based on P/E ratios, BIIB trades at a lower multiple (20.0x vs 37.8x).
Which is growing faster: LGND or BIIB?
LGND has higher revenue growth at 0.4% vs -0.1% for BIIB.
Which company is more profitable: LGND or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 64.3% for LGND.
Which is the larger company: LGND or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.03B compared to $4.62B for LGND.
Should I buy LGND or BIIB in 2026?
Both LGND and BIIB have investment merit. LGND trades at $231.82 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LGND and BIIB stock?
Key differences: Market Cap ($4.62B vs $26.03B), P/E Ratio (37.8x vs 20.0x), Revenue Growth (0.4% vs -0.1%), Gross Margin (64.3% vs 78.9%).